692 related articles for article (PubMed ID: 11805221)
1. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
McNaull B; Trang T; Sutak M; Jhamandas K
Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
5. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
Crain SM; Shen KF
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice.
Singh VP; Patil CS; Jain NK; Singh A; Kulkarni SK
Pharmacology; 2003 Nov; 69(3):115-22. PubMed ID: 14512696
[TBL] [Abstract][Full Text] [Related]
11. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
12. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
13. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
14. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
Ibuki T; Dunbar SA; Yaksh TL
Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
[TBL] [Abstract][Full Text] [Related]
15. Dissociable effects of ultralow-dose naltrexone on tolerance to the antinociceptive and cataleptic effects of morphine.
Tuerke KJ; Beninger RJ; Paquette JJ; Olmstead MC
Behav Pharmacol; 2011 Sep; 22(5-6):558-63. PubMed ID: 21555938
[TBL] [Abstract][Full Text] [Related]
16. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
[TBL] [Abstract][Full Text] [Related]
18. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
19. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
Crain SM; Shen KF
Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
